These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6421513)

  • 21. Electrocardiographic Changes in Liver Cirrhosis-Clues for Cirrhotic Cardiomyopathy.
    Toma L; Stanciu AM; Zgura A; Bacalbasa N; Diaconu C; Iliescu L
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32050594
    [No Abstract]   [Full Text] [Related]  

  • 22. Alterations of glucose metabolism in chronic liver disease.
    Del Vecchio Blanco C; Gentile S; Marmo R; Carbone L; Coltorti M
    Diabetes Res Clin Pract; 1990 Jan; 8(1):29-36. PubMed ID: 2153513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of telbivudine efficacy in treatment-naive patients with hepatitis B virus-related compensated and decompensated cirrhosis in 96 weeks.
    Yang X; Li J; Zhou L; Liu J; Wang J; Lu W
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):396-403. PubMed ID: 24569820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum apolipoprotein and lipoprotein levels in patients with diabetes mellitus type 2].
    Gosiewska A; Zarzycki W; Depta K; Składanek J; Kinalski M; Lopaczyński W
    Wiad Lek; 1989 Apr; 42(7):436-40. PubMed ID: 2629300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoproteins and coronary artery disease.
    Kottke BA; Zinsmeister AR; Holmes DR; Kneller RW; Hallaway BJ; Mao SJ
    Mayo Clin Proc; 1986 May; 61(5):313-20. PubMed ID: 3702492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Deviations in the level of serum lipids and higher fatty acids in liver cirrhosis and chronic hepatitis].
    Koĭchev K; Vurbanov G
    Vutr Boles; 1977; 16(2):65-71. PubMed ID: 878449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases.
    Morelli A; Vedovelli A; Fiorucci S; Angelini GP; Fini C; Palmerini CA; Floridi A
    Clin Chim Acta; 1985 May; 148(2):87-95. PubMed ID: 3888456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased apolipoprotein levels in women with hyperprolactinemia related to increased estradiol level: effect of hepatic lesion?
    Oravec S; Tomecková E; Oravec D; Klacanský T; Blasková O; Valach A
    Endocrinol Exp; 1985 Dec; 19(4):312-6. PubMed ID: 3936699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum apolipoproteins and lipids in severe injury as influenced by nutrition. A pilot study].
    Hailer S; Adolph M; Eckart J; Wolfram G
    Infusionsther Klin Ernahr; 1982 Dec; 9(6):302-9. PubMed ID: 6819233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.
    Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M
    Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of feeding diets of varying fatty acid composition on apolipoprotein expression in newborn swine.
    Wang H; Hunter F; Black DD
    Am J Physiol; 1998 Oct; 275(4):G645-51. PubMed ID: 9756492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic abnormalities in chronic aggressive hepatitis and liver cirrhosis.
    Ruggiero G; De Biasi R; Attanasio S; Bile G; Giusti G
    Acta Hepatogastroenterol (Stuttg); 1975 Aug; 22(4):221-8. PubMed ID: 1179944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selected parameters of lipid metabolism in acute and chronic liver diseases].
    Sowa J; Malkiewicz-Wasowicz B; Zmudzińska D; Odrobina S
    Pol Arch Med Wewn; 1981 Feb; 65(2):141-50. PubMed ID: 7291036
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of plasma lipids in patients with liver cirrhosis and hepatitis].
    Platzer S; Sailer S; Sandhofer F; Braunsteiner H
    Wien Klin Wochenschr; 1966 Jan; 78(4):56-8. PubMed ID: 5962258
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis?
    Abbasi A; Bhutto AR; Butt N; Lal K; Munir SM
    J Coll Physicians Surg Pak; 2012 Aug; 22(8):484-7. PubMed ID: 22868011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum lipids and apolipoproteins AI, B100, CI and CII in noninsulin-dependent diabetics].
    Liu BW; Liang JS; Fu MD
    Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):627-9, 653-4. PubMed ID: 3147855
    [No Abstract]   [Full Text] [Related]  

  • 38. [At II in liver diseases. Comparison between immunological determination and that with chromogenic substrate].
    Carmignoto F; Schivo P; Zotti S; Ceriotti G
    Arch Sci Med (Torino); 1980; 137(3):467-70. PubMed ID: 6786256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease.
    Vergani C; Trovato G; Delù A; Pietrogrande M; Dioguardi N
    J Clin Pathol; 1978 Aug; 31(8):772-8. PubMed ID: 690242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.